<?xml version="1.0" encoding="UTF-8"?>
<ref id="B26">
 <label>26</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kamoun</surname>
    <given-names>WS</given-names>
   </name>
   <name>
    <surname>Ley</surname>
    <given-names>CD</given-names>
   </name>
   <name>
    <surname>Farrar</surname>
    <given-names>CT</given-names>
   </name>
   <name>
    <surname>Duyverman</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Lahdenranta</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Lacorre</surname>
    <given-names>DA</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice</article-title>. 
  <source>J Clin Oncol: Off J Am Soc Clin Oncol</source> (
  <year>2009</year>) 
  <volume>27</volume>:
  <page-range>2542–52</page-range>.  
  <pub-id pub-id-type="doi">10.1200/jco.2008.19.9356</pub-id>
 </mixed-citation>
</ref>
